Inhaled insulin Afrezza has launched in India, offering a needle-free option for diabetes management. Designed to overcome ...

Inhaled insulin, a patient-friendly alternative to injections, has been introduced in India. This new method aims to alleviate 'needle phobia' and improve diabetes management.

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 5 includes Hormel Foods, Hut 8, IonQ, Kodiak AI, ...

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those ...

This form of rapid-acting inhaled insulin, recently introduced in India by the name Afrezza, is said to offer an important ...